This event draws the challenges of creating an innovative service tissue bank to accelerate the research and development processes of biotechnology and pharmaceutical companies worldwide. Asterand two major challenges involved in achieving a standardized approach to the collection of tissue samples in hospitals around the world and the highest possible quality of tissue samples sent to their primary customers, Amgen. Despite the identified need for high-quality tissue samples Aste … Read more »

This event draws the challenges of creating an innovative service tissue bank to accelerate the research and development processes of biotechnology and pharmaceutical companies worldwide. Asterand two major challenges involved in achieving a standardized approach to the collection of tissue samples in hospitals around the world and the highest possible quality of tissue samples sent to their primary customers, Amgen. Despite the identified need for high-quality tissue samples Asterand was experiencing several quality control problems in their processes and procedures. Tissue samples were poorly packed or labeled incorrectly delivered at the wrong time or the wrong place. In addition, there were quality problems with the RNA analysis of the samples, which was a decisive factor for the usability of the tissue sample for the research and development of new therapies and drugs. The head of pathology at Amgen California plant threatened to terminate their existing order and communicate the failure Asterand for all employees of the company who have a devastating domino effect in the industry and would probably destroy all chances for future jobs with Asterand. Should this happen, Asterand would not be able to secure contracts with customers and was in danger of losing investors and go bankrupt.
«Hide

from
Anne Snowdon,
Hannah standing Rasmussen
David Maslach
Source: Ivey Publishing
11 pages.
Release Date: 29 October 2012. Prod #: W12286-PDF-ENG
Asterand: Learning from Failure HBR case solution